BrainsWay Ltd. BWAY recently announced an expansion of insurance coverage for its Deep TMS therapy in adolescent depression.

BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain ...

Transcranial magnetic stimulation (TMS) was first approved for the treatment of major depressive disorder (MDD) in 2008. Because it worked well for depression by using a strong magnetic field to ...

Sponsored: The holidays are considered a time of joy, but others face challenges. TMS Therapy at Sunrise Psychiatry may help.

Brainsway ( ($BWAY) ) has provided an announcement. On December 22, 2025, BrainsWay Ltd. reported that Optum Behavioral Health, part of ...

Please provide your email address to receive an email when new articles are posted on . Transcranial magnetic stimulation targets the central executive network. 80% of patients responded by 20 ...

Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.

DULUTH — Depression had been an uninvited aspect of Gail Sundstrum’s life since she experienced her first episode with it in 1993. “I couldn’t stop shaking. I couldn’t stop crying. I couldn’t eat. I ...

KANAWHA COUNTY, W.Va. (WCHS) — With the new year here and winter weather upon us, many people are dealing with seasonal depression. Studies show that depression is impacting nearly 21 million ...

New findings from researchers at UCLA Health suggest that measuring changes in how pupils react to light could help predict recovery from depression and personalize transcranial magnetic stimulation ...

Please provide your email address to receive an email when new articles are posted on . Ketamine provides rapid action, and transcranial magnetic stimulation offers durability. Both treatments involve ...

NEW YORK ― Transcranial magnetic stimulation (TMS) is a cost-effective treatment option for patients with resistant major depressive disorder (MDD), according to a new economic analysis. "It's mainly ...